b
r
c
pest
de
petit
rumin
ppr
highli
contagi
diseas
small
rumin
lead
high
morbid
mortal
therebi
result
devast
econom
consequ
livestock
industri
ppr
current
endem
across
part
asia
africa
two
region
highest
concentr
poor
peopl
world
sheep
goat
particularli
contribut
significantli
toward
uplift
livelihood
poor
margin
farmer
region
context
ppr
directli
affect
viabil
sheep
goat
husbandri
emerg
major
hurdl
develop
region
control
ppr
region
could
significantli
contribut
poverti
allevi
therefor
offic
intern
de
epizooti
oie
food
agricultur
organ
fao
target
control
erad
ppr
prioriti
order
achiev
goal
potent
safe
efficaci
liveattenu
ppr
vaccin
longlast
immun
avail
immunoprophylaxi
howev
liveattenu
ppr
vaccin
thermolabil
need
mainten
effect
cold
chain
deliv
field
addit
infect
anim
differenti
vaccin
anim
overcom
limit
recombin
vaccin
develop
review
comprehens
describ
latest
develop
ppr
vaccin
ppr
one
contagi
fatal
diseas
anim
primarili
affect
small
rumin
current
endem
part
asia
africa
middl
east
long
time
past
ppr
misdiagnos
rinderpest
major
breakthrough
histori
anim
plagu
took
place
gargadennec
lalann
work
ivori
coast
identifi
diseas
sheep
goat
similar
differ
rinderpest
transmiss
cattl
diseas
later
name
pest
de
petit
rumin
ppr
past
sever
common
name
goat
plagu
ovin
rinderpest
plagu
small
rumin
kata
pest
de
petit
rumin
ppr
ppr
french
denomin
stand
small
rumin
plagu
adopt
scientif
denomin
diseas
commonli
use
worldwid
mornet
colleagu
demonstr
ppr
rinderpest
virus
close
relat
antigen
mornet
et
al
caus
agent
ppr
viru
pprv
isol
first
time
sheep
cell
cultur
gilbert
monnier
gilbert
monnier
bourdin
laurentvauti
bourdin
laurentvauti
observ
viru
first
time
electron
microscop
pprv
classifi
member
genu
morbilliviru
subfamili
paramyxovirina
famili
paramyxovirida
order
mononegaviral
gibb
et
al
seven
known
member
genu
morbilliviru
measl
viru
mv
rinderpest
viru
rpv
pprv
canin
distemp
viru
cdv
cetacean
morbilliviru
cemv
phocin
distemp
viru
pdv
felin
morbilliviru
fmv
kumar
et
al
morbillivirus
caus
diseas
human
anim
diallo
base
nucleotid
sequenc
analysi
fusion
f
andor
nucleoprotein
n
gene
pprv
strain
group
four
genet
lineag
type
iv
wherea
pprv
strain
belong
four
genet
lineag
preval
africa
pprv
strain
asia
belong
type
iv
lineag
kumar
et
al
introduct
asian
lineag
type
iv
pprv
africa
report
first
time
ppr
outbreak
morocco
kwiatek
et
al
pprv
lineag
type
iii
also
report
asia
shaila
et
al
lineag
classif
may
use
monitor
pprv
circul
trace
sourc
outbreak
although
perfect
cross
protect
believ
occur
among
variou
pprv
strain
lineag
classif
could
help
prepar
homolog
vaccin
adequ
immun
pprv
primarili
caus
diseas
goat
sheep
sever
speci
may
also
succumb
infect
cattl
pig
seroconvert
upon
contact
infect
sheep
goat
without
detect
clinic
diseas
nawath
taylor
taylor
abegund
therefor
act
deadend
host
gibb
et
al
howev
evid
pyrexia
oral
lesion
calv
mornet
et
al
mornet
et
al
fatal
infect
buffalo
govindarajan
et
al
observ
experiment
infect
pprv
detect
pprv
antibodi
anim
natur
host
cattl
buffalo
camel
suggest
natur
transmiss
pprv
among
speci
field
condit
balamurugan
et
al
khalafalla
et
al
khan
et
al
woma
et
al
b
pprv
identifi
camel
found
phylogenet
ident
small
rumin
albina
et
al
occasion
viru
may
overcom
innat
resist
host
produc
clinic
diseas
late
potenti
camel
act
reservoir
host
pprv
infect
also
suggest
abraham
epidemiolog
ppr
end
domest
anim
rather
also
involv
wild
anim
aziz
ul
et
al
ratta
et
al
sever
clinic
diseas
high
mortal
due
pprv
infect
record
dorca
gazel
gazella
dorca
gur
albayrak
nubian
ibex
capra
ibex
nubiana
laristan
sheep
ovi
orientali
laristani
gemsbok
oryx
gazellaa
couacyhymann
et
al
kinn
et
al
lembo
et
al
likewis
subclin
infect
report
nilgai
tragelaphina
arabian
gulf
furley
et
al
experiment
infect
pprv
american
white
deer
odocoileu
virginianu
also
report
hamdi
dardiri
clinic
serolog
evid
also
suggest
involv
gazel
deer
antelop
small
wild
rumin
abu
elzein
et
al
alnaeem
et
al
peridomest
rat
also
suspect
play
role
epizootiolog
pprv
goat
nigeria
experiment
infect
rat
subclin
fail
transmit
infect
goat
komolaf
et
al
evid
impli
mainten
pprv
environ
anim
natur
host
wild
anim
couacyhymann
et
al
comprehens
descript
effect
prophylact
measur
rinderpest
provid
lancisi
still
valid
infecti
diseas
adopt
oie
key
prophylact
method
suggest
includ
sanitari
measur
quarantin
slaughter
compens
destruct
carcass
infect
materi
blancou
sinc
rinderpest
cattl
somewhat
similar
smallpox
human
assum
like
small
pox
could
control
variol
sever
trial
conduct
europ
realiz
rinderpest
inocul
could
danger
practic
diseas
free
herd
taylor
et
al
howev
layard
made
interest
observ
distemp
neighborhood
herd
prevent
anim
rinderpest
probabl
due
cross
protect
provid
distemp
caus
agent
rinderpest
review
refer
method
inocul
also
taken
consider
protect
cattl
rinderpest
peter
camper
tri
inocul
lung
fragment
contain
small
worm
found
dead
anim
believ
worm
might
harbour
caus
agent
diseas
leclainch
inocul
trial
continu
expert
realiz
stampingout
possibl
free
rang
anim
koch
tri
bile
rinderpest
infect
anim
inocul
increas
spread
diseas
rather
prevent
inocul
serum
obtain
recov
anim
result
protect
recipi
rinderpest
kool
turner
dr
william
hutchin
develop
earli
vaccin
rinderpest
base
organ
extract
treat
anim
major
breakthrough
achiev
dr
j
edward
director
imperi
bacteriolog
laboratori
mukteswar
india
develop
effect
vaccin
rinderpest
attenu
viru
serial
passag
time
goat
vaccin
provid
longlast
immun
rinderpest
cattl
buffalo
without
side
effect
develop
liveattenu
tissu
cultur
vaccin
rinderpest
attempt
made
develop
formalininactiv
rinderpest
viru
vaccin
howev
vaccin
found
suitabl
protect
cattl
rpv
morbillivirus
inactiv
rinderpest
viru
vaccin
produc
shortterm
immun
respons
appel
et
al
moreov
case
measl
viru
administr
inactiv
vaccin
increas
diseas
patholog
subsequ
expos
wildtyp
viru
taylor
et
al
likewis
hyperimmun
serum
also
provid
shortterm
protect
taylor
et
al
endem
region
diseas
prevent
accomplish
use
liveattenu
ppr
vaccin
howev
nonendem
region
threat
europ
liveattenu
vaccin
usual
recommend
veterinari
author
thu
inactiv
vaccin
remain
viabl
altern
therefor
recent
time
new
formul
inactiv
ppr
vaccin
develop
test
one
vaccin
develop
cosseddu
provid
steril
immun
found
resist
challeng
virul
pprv
though
two
dose
vaccin
requir
cosseddu
et
al
anoth
inactiv
ppr
vaccin
formul
delta
inulin
agonist
oligonucleotid
adjuv
induc
seroconvers
rat
goat
inject
immun
goat
seroconvert
pprv
day
remain
seroposit
day
end
experiment
period
ronchi
et
al
suggest
inactiv
vaccin
combin
delta
inulin
adjuv
repres
promis
altern
live
attenu
ppr
vaccin
howev
vivo
challeng
studi
requir
warrant
use
field
sabin
colleagu
establish
landmark
adapt
polioviru
cell
cultur
system
pioneer
work
pave
way
attenu
vaccin
develop
virus
krugman
et
al
sabin
also
facilit
process
attenu
rpv
henc
develop
tissu
cultur
rinderpest
vaccin
tcrv
vaccin
led
success
global
erad
rinderpest
plowright
ferri
observ
rpv
attenu
initi
passag
viru
exhibit
minor
surg
pathogen
later
wane
lead
develop
avirul
strain
passag
level
plowright
ferri
begin
homolog
ppr
vaccin
avail
heterolog
rinderpest
vaccin
formal
rinderpest
spleen
gargadennec
lalann
lapinis
rinderpest
vaccin
mornet
et
al
use
control
ppr
variabl
success
subsequ
success
applic
tcrv
bourdin
et
al
protect
goat
ppr
oie
recommend
ppr
prophylaxi
tcrv
vaccin
provid
protect
year
ppr
marin
et
al
taylor
howev
vaccin
later
ban
possibl
interfer
global
rinderpest
erad
program
grep
achiev
rinderpest
free
zone
henc
necessit
develop
homolog
ppr
vaccin
first
success
vitro
adapt
pprv
carri
gilbert
monnier
success
propag
pprv
primari
liver
cell
sheep
wherein
cytopath
effect
cpe
manifest
appear
larg
syncytia
gilbert
monnier
similarli
cpe
manifest
form
cell
round
detach
syncytia
format
laurent
observ
follow
infect
rpv
calf
liver
cell
plowright
ferri
initi
pprv
form
microsyncytia
becom
larger
infect
progress
success
passag
pprv
sheep
liver
cell
result
reduc
pathogen
author
could
obtain
complet
avirul
strain
even
passag
level
viru
induc
slight
hyperthermia
studi
benazet
wherein
pprv
serial
propag
sheep
liver
cell
also
result
complet
avirul
strain
even
passag
review
refer
diallo
et
al
unsuccess
attenu
pprv
previou
worker
could
attribut
insuffici
quantiti
viru
inoculum
use
gener
mutant
type
cell
cultur
system
employ
inher
natur
pprv
strain
use
attenu
diallo
colleagu
abl
obtain
first
attenu
pprv
strain
serial
passag
pprv
vero
cell
diallo
et
al
adapt
observ
begin
serial
passag
passag
level
cpe
could
observ
day
postinfect
howev
passag
period
reduc
day
like
case
rpv
pprv
also
lost
virul
quickli
upon
success
passag
vero
cell
passag
viru
induc
slight
fever
anim
becam
complet
avirul
passag
also
observ
vaccin
viru
passag
use
immun
goat
elicit
protect
antibodi
respons
earli
day
postvaccin
diallo
et
al
sever
vaccin
trial
vaccin
conduct
sheep
goat
without
untoward
effect
besid
vaccin
sheep
goat
resist
challeng
virul
viru
transmit
challeng
viru
incontact
suscept
anim
protect
antibodi
persist
year
vaccin
anim
taken
togeth
vaccin
demonstr
efficaci
protect
sheep
goat
virul
pprv
though
begin
use
worldwid
protect
genet
defin
lineag
pprv
subsequ
lineag
type
iv
vaccin
also
develop
goat
isol
sungri
himach
pradesh
india
use
develop
lineagespecif
lineag
type
iv
ppr
vaccin
india
propag
marmoset
lymphoblastoid
cell
vero
cell
first
passag
vero
cell
wherein
viru
becam
avirul
passag
review
refer
sen
et
al
vaccin
base
extens
test
experiment
well
field
found
safe
efficaci
provid
steril
immun
ppr
small
rumin
least
year
sen
et
al
vaccin
use
mass
immun
ppr
control
program
carri
india
sinc
likewis
tamil
nadu
veterinari
anim
scienc
univers
tanuva
india
sheep
origin
goat
origin
serial
propag
vero
cell
obtain
avirul
strain
passag
level
sen
et
al
vaccin
use
southern
indian
state
equal
efficaci
safe
vaccin
vero
cell
line
test
isol
pprv
clinic
specimen
limit
success
kumar
et
al
signal
lymphocyt
activ
molecul
slam
serv
primari
cellular
receptor
morbillivirus
meng
et
al
sarkar
et
al
tatsuo
yanagi
introduct
slam
cell
facilit
morbilliviru
replic
pawar
et
al
howev
amino
acid
sequenc
slam
vari
speci
often
requir
adapt
particular
viru
differ
version
slam
human
canin
goat
cattl
meng
et
al
sarkar
et
al
contrari
highli
conserv
differ
mammal
unlik
slam
need
receptor
adapt
viru
compar
vero
cell
express
canin
slam
verodogslam
express
cell
found
highli
sensit
pprv
isol
versu
effici
swab
sampl
versu
effici
tissu
specimen
fakri
et
al
moreov
viru
titer
significantli
higher
suggest
superior
verodogslam
develop
ppr
diagnost
well
viru
titrat
ppr
vaccin
contain
tissu
cultur
infect
dose
cell
cultur
attenu
pprv
administ
via
subcutan
rout
believ
protect
vaccin
anim
year
matern
antibodi
interfer
vaccin
therefor
kid
born
vaccin
anim
must
immun
age
month
stage
level
matern
antibodi
quit
enough
interfer
vaccin
viru
ata
et
al
ppr
vaccin
consid
quit
safe
without
immunosuppress
effect
host
rajak
et
al
though
gener
recommend
sick
anim
healthi
anim
close
contact
pprvinfect
anim
outbreak
shelf
life
liveattenu
pprv
vaccin
year
c
sen
et
al
sinc
pprv
vaccin
mostli
requir
use
hot
humid
climat
south
asia
africa
begum
et
al
therefor
mainten
cold
chain
essenti
requir
transport
vaccin
field
significantli
increas
overal
cost
vaccin
packag
circumv
problem
cold
chain
mainten
rang
improv
freezedri
method
develop
enhanc
thermostabilti
ppr
vaccin
marin
et
al
develop
lyophil
vero
celladapt
rinderpest
vaccin
stabil
lactalbumin
hydrolys
sucros
wherein
moistur
content
vaccin
greatli
reduc
therebi
increas
thermost
tcrv
vaccin
marin
et
al
similarli
worral
et
al
develop
rapid
method
dehydr
preserv
live
attenu
pprv
vaccin
xerovac
wherein
viru
dilut
steril
wv
aqueou
solut
trehalos
dehydr
subject
dri
simpl
dehydr
result
vaccin
abl
resist
c
period
day
without
major
loss
potenc
worral
et
al
silva
tri
variou
strategi
increas
thermost
ppr
vaccin
use
tri
trehalos
increas
viru
halflif
liquid
formul
h
c
month
c
ii
tristrehalos
also
enhanc
thermost
lyophil
ppr
vaccin
wherein
viral
titer
maintain
rel
longer
time
log
loss
c
month
log
loss
c
h
log
loss
c
h
iii
replac
fructos
glucos
enhanc
intrins
pprv
vaccin
stabil
term
higher
stabil
higher
viru
product
log
increas
iv
increas
concentr
nacl
facilit
releas
viru
infect
cell
reduc
cellassoci
fraction
viru
silva
et
al
silva
et
al
heavi
water
also
report
increas
thermost
polio
wu
et
al
yellow
fever
vaccin
adebayo
et
al
order
increas
thermost
ppr
vaccin
combin
stabil
heavi
water
also
explor
reconstitut
pprvjhansi
vaccin
stabil
c
use
stabil
e
trehalos
calcium
chlorid
magnesium
chlorid
could
maintain
protect
titer
h
reconstitut
diluent
contain
nacl
mgso
c
protect
titer
maintain
h
review
refer
sen
et
al
vaccin
base
deuter
viru
also
develop
wherein
viru
grown
cell
cultur
media
contain
heavi
water
vaccin
diluent
contain
heavi
water
mgcl
exposur
c
c
deuter
pprv
vaccin
maintain
titer
greater
tcid
ml
day
compar
convent
ppr
vaccin
could
maintain
titer
day
combin
heavi
water
mgcl
found
better
reconstitut
diluent
heavi
water
alon
deuter
convent
ppr
vaccin
sen
et
al
howev
vaccin
margin
advantag
term
thermost
tabl
success
ppr
control
program
depend
larg
effect
deliveri
vaccin
hot
humid
climat
asiaafrica
therefor
need
research
develop
thermost
ppr
vaccin
addit
use
new
stabil
employ
improv
freez
dri
method
vaccin
base
thermoadapt
ta
pprv
also
develop
balamurugan
et
al
riyesh
et
al
one
vaccin
develop
use
pprvindia
strain
viru
initi
grown
vero
cell
passag
c
addit
passag
perform
tavero
cell
c
result
attenu
viru
ta
pprv
use
vaccin
candid
sheep
goat
found
safe
potent
efficaci
vaccin
candid
thu
provid
altern
exist
ppr
vaccin
tabl
howev
extens
clinic
trial
need
carri
use
vaccin
field
like
tcrv
liveattenu
ppr
vaccin
effect
vaccin
provid
longlast
immun
follow
singl
immun
howev
vaccin
two
main
drawback
first
immun
respons
ident
natur
infect
therefor
possibl
differenti
infect
vaccin
anim
diva
import
issu
serolog
survey
would
lead
confus
determin
whether
viru
elimin
vaccin
therefor
gener
recommend
vaccin
use
control
diseas
region
countri
must
prove
suscept
anim
popul
free
infect
employ
diva
test
secondli
vaccin
thermolabil
requir
cold
chain
deliv
vaccin
hot
arid
environ
endem
region
asia
africa
make
costli
inconveni
affair
recombin
dna
technolog
use
produc
new
vaccin
plethora
organ
success
hepat
b
vaccin
human
overcom
thermol
recombin
vaccin
develop
rinderpest
romero
et
al
likewis
diva
vaccin
also
develop
rinderpest
romero
et
al
could
implement
grep
last
phase
vaccinia
viru
larg
genom
contain
sever
nonessenti
gene
replac
foreign
gene
therefor
consid
suitabl
genet
manipul
mackett
et
al
vacciniarabi
recombin
vaccin
first
vaccin
produc
elicit
protect
immun
respons
could
withstand
extrem
temperatur
field
commonli
use
europ
usa
control
rabi
wild
anim
brochier
et
al
vacciniarinderpest
recombin
also
develop
yilma
et
al
use
f
h
protein
gene
howev
vaccin
base
wr
strain
vaccinia
viru
consid
quit
safe
licens
absenc
smallpox
one
import
concern
use
vaccinia
viru
vector
recombin
vaccin
safeti
vaccin
particularli
africa
signific
popul
immunocompromis
due
infect
moreov
vaccinia
viru
vector
vaccin
produc
sever
lesion
site
inocul
anim
probabl
due
insuffici
attenu
therefor
suffici
attenu
strain
yamanouchi
et
al
wyeth
verardi
et
al
examin
subsequ
establish
vaccin
strain
capripox
virus
caus
agent
sheep
goat
pox
also
use
produc
recombin
rinderpest
ppr
vaccin
capripox
vector
rinderpest
vaccin
three
main
advantag
firstli
longlast
immun
three
year
cattl
secondli
could
protect
cattl
two
diseas
rinderpest
lumpi
skin
diseas
lsd
thirdli
due
strong
antigen
relationship
within
genu
morbilliviru
goat
sheep
could
also
protect
ppr
romero
et
al
b
howev
disadvantag
preexist
antibodi
lsd
viru
lsdv
interfer
vaccin
intak
ngichab
et
al
capripox
viru
vector
vaccin
also
develop
ppr
act
dual
vaccin
protect
ppr
sheep
goat
pox
berh
et
al
chen
et
al
though
vaccin
found
rel
thermost
elicit
optimum
antibodi
respons
probabl
preexist
immun
vector
chen
et
al
later
fowlpox
fp
viru
vector
success
use
human
use
rumin
elicit
poor
antibodyand
cellmedi
immun
respons
cubilloszapata
et
al
sinc
limit
number
viral
protein
f
andor
h
use
recombin
antigen
absenc
pprv
n
protein
vaccin
prepar
allow
serolog
identif
infect
anim
therefor
serv
marker
diva
vaccin
howev
vaccin
often
requir
multipl
dose
reduc
efficaci
compar
liveattenu
vaccin
vaccin
safe
use
counti
risk
immun
short
durat
diva
possibl
convent
liveattenu
vaccin
diallo
et
al
b
diallo
et
al
success
ppr
vaccin
use
globe
ppr
control
program
provid
longlast
immun
thermolabil
diva
possibl
convent
ppr
vaccin
stabil
improv
freez
dri
method
vero
celladapt
vaccin
stabil
lactalbumin
hydrolys
sucros
move
forward
beyond
experiment
stage
licens
hamper
due
controversi
releas
genet
manipul
organ
replicationdefici
adenoviru
consid
better
recombin
vector
use
small
rumin
unlik
human
be
anim
lack
preexist
immun
vector
thacker
et
al
like
liveattenu
pprv
vaccin
immun
goat
adh
alon
combin
adf
found
induc
potent
antibodi
cell
mediat
immun
respons
herbert
et
al
qin
et
al
wang
et
al
though
combin
adh
adf
induc
better
protect
adh
adf
alon
holzer
et
al
revers
genet
approach
studi
phenotyp
effect
engin
mutat
gene
made
possibl
genet
alter
viral
rna
genom
dna
copi
cdna
rpv
genom
manipul
use
approach
introduc
sitespecif
mutat
barrett
therebi
allow
altern
approach
develop
marker
vaccin
approach
use
add
marker
gene
posit
marker
vaccin
delet
antigen
compon
neg
marker
vaccin
initi
vaccin
produc
insert
green
fluoresc
protein
gfp
gene
p
gene
rpv
genom
result
vaccin
found
efficaci
resist
virul
rpv
challeng
along
elicit
antibodi
marker
gfp
walsh
et
al
anoth
vaccin
develop
insert
influenza
viru
hemagglutinin
ha
gene
vaccin
produc
strong
antibodi
respons
rpv
well
marker
ha
resist
challeng
virul
rpv
walsh
et
al
develop
revers
genet
system
pprv
hu
et
al
muniraju
et
al
muniraju
et
al
develop
two
type
recombin
pprv
construct
posit
marker
pprv
construct
insert
enhanc
gfp
egfp
p
gene
neg
marker
construct
delet
monoclon
antibodi
bind
site
h
protein
key
compon
current
diagnost
competit
h
elisa
celisa
neither
insert
egfp
mutat
h
protein
affect
function
viabil
recombin
pprv
construct
use
vaccin
use
vaccin
strain
backbon
resist
challeng
virul
pprv
transmit
vaccin
viru
suscept
incontact
anim
howev
monoclon
antibodi
found
bind
mutat
form
pprv
h
protein
thu
allow
diva
contrarili
epitop
delet
serv
success
diva
vaccin
rpv
buczkowski
et
al
newcastl
diseas
viru
ndv
peeter
et
al
classic
swine
fever
viru
wehrl
et
al
recombin
pprv
express
fmdv
gene
rpprv
also
gener
yin
et
al
insert
fmdv
pprv
backbon
neither
impair
replic
recombin
viru
vitro
affect
immunogen
induc
neutral
antibodi
pprv
goat
administr
recombin
also
induc
fmdv
neutral
antibodi
goat
resist
challeng
virul
fmdv
vaccin
potenti
serv
dual
live
vector
vaccin
pprv
fmdv
yin
et
al
one
potenti
problem
vaccin
develop
use
revers
genet
approach
marker
protein
may
incorpor
viru
envelop
therefor
may
alter
host
tropism
pathogen
order
avoid
complic
mutant
version
influenza
ha
protein
mutant
disrupt
bind
viru
host
cell
receptor
employ
produc
recombin
marker
vaccin
walsh
et
al
toward
end
grep
area
declar
free
rinderpest
could
use
rpv
vaccin
strain
vaccin
rinderpest
ppr
therefor
altern
neg
marker
vaccin
produc
gener
chimer
virus
gene
immunogen
protein
deriv
relat
virus
ie
pprv
rpv
h
f
gene
rpv
replac
correspond
gene
pprv
result
chimer
rpvpprv
recombin
viru
vaccin
da
et
al
virusspecif
serolog
respons
vaccin
identifi
specif
elisa
therefor
allow
discrimin
infect
vaccin
anim
later
n
proteinbas
chimer
rpvpprv
marker
vaccin
develop
provid
protect
challeng
virul
rpv
cattl
parida
et
al
base
upon
antigen
bind
specif
idiotyp
share
characterist
group
immunoglobulin
cell
receptor
tcr
molecul
idiotyp
locat
variabl
region
antibodi
molecul
immun
respons
regul
number
idiotyp
determin
id
counterpart
antiidiotyp
antibodi
antiid
jern
intern
imag
antiid
b
resembl
origin
antigen
mcnamara
kohler
recogn
idiotyp
determin
within
antigen
combin
site
intern
imag
b
antibodi
shown
immunogen
hepat
b
viru
kennedi
et
al
b
bluetongu
viru
zhou
intern
imag
rpv
pprv
hhn
protein
also
shown
elicit
viru
specif
antibodi
cellmedi
immun
respons
mous
model
vani
et
al
moreov
dna
encod
vh
region
also
shown
elicit
longlast
antibodi
cellmedi
immun
respons
mous
complet
absenc
viral
antigen
vani
et
al
dna
vaccin
code
heavi
chain
variabl
region
intern
imag
antiidiotyp
antibodi
mimic
region
hn
protein
pprv
also
found
capabl
elicit
antibodi
cellmedi
immun
respons
sheep
complet
absenc
viral
antigen
apsana
et
al
dnabas
vaccin
consid
heat
stabl
gener
immun
respons
desir
antigen
pprv
hn
protein
vaccin
therefor
potenti
overcom
limit
thermosensit
diva
current
liveattenu
ppr
vaccin
use
mass
immun
field
baculovirusexpress
rpv
h
f
protein
use
antigen
subunit
vaccin
yamanouchi
et
al
though
elicit
strong
neutral
antibodi
respons
provid
protect
cattl
virul
rpv
bassiri
et
al
howev
baculovirusexpress
h
protein
incorpor
immunostimul
complex
iscom
good
level
protect
achiev
virul
viru
challeng
iscom
known
induc
cellmedi
immun
respons
enni
et
al
therefor
appear
cellmedi
immun
respons
major
factor
induc
protect
immun
respons
morbillivirus
recombin
baculoviru
construct
coexpress
pprv
h
n
protein
allow
bud
ppr
viruslik
particl
vlp
insect
cell
membran
liu
et
al
vlp
found
induc
potent
virusspecif
neutral
antibodi
mice
suggest
potenti
vlpbase
vaccin
candid
ppr
zhong
et
al
administ
vaccin
needl
prick
need
huge
veterinari
infrastructur
therefor
significantli
affect
diseas
control
program
context
edibl
vaccin
ppr
could
attract
perspect
recombin
rpv
h
protein
produc
transgen
tobacco
peanut
plant
shown
reactiv
hmonospecif
convalesc
sera
inocul
intraperiton
transgen
plant
deriv
protein
produc
high
titer
antibodi
mice
neutral
rpv
infect
similarli
leav
transgen
peanut
express
rpvh
fed
mice
cattl
induc
neutral
antibodi
lymphoprolif
respons
khandelw
et
al
khandelw
et
al
b
satyavathi
et
al
though
still
earli
stage
develop
studi
suggest
potenti
oral
edibl
vaccin
morbilliviru
infect
bombyx
mori
nucleopolyhedroviru
display
immunodomin
ectodomain
h
glycoprotein
rpv
f
glycoprotein
pprv
rahman
et
al
semliki
forest
viru
sfv
express
h
protein
callagi
et
al
silk
worm
larvaeexpress
recombin
f
protein
saravanan
et
al
recombin
vaccin
develop
efficaci
regard
protect
yet
evalu
natur
host
modifi
vaccin
viru
ankara
mva
express
pprv
f
h
protein
induc
resist
challeng
virul
pprv
also
develop
need
two
dose
vaccin
prior
challeng
review
refer
sen
et
al
establish
minimum
vaccin
dose
effici
protect
larg
scale
clinic
trial
extens
safeti
trial
valid
companion
diagnost
test
key
issu
need
address
use
nextgener
vaccin
field
control
erad
ppr
reduc
stress
caus
anim
econom
cost
overal
vaccin
packag
mixtur
organ
commonli
use
singl
vaccin
call
combin
vaccin
et
al
lasaro
et
al
combin
vaccin
develop
wide
rang
organ
exampl
fmd
hemorrhag
septicemia
hs
fmd
hs
black
quarter
bq
trival
vaccin
chhabra
et
al
mycobacterium
bovi
brucella
hu
et
al
escherichia
coli
rotaviru
snodgrass
waltnertoew
et
al
bovin
respiratori
syncyti
viru
bovin
viral
diarrhea
viru
infecti
bovin
rhinotrach
viru
parainfluenza
viru
mannheimia
haemolytica
develop
combin
parvoviru
hepat
leptospirosi
parainfluenzaviru
coronaviru
adenoviru
dhlpp
dhlppc
also
practic
dog
cat
burgher
et
al
gribencha
selimov
untoward
effect
observ
due
presenc
multipl
antigenspathogen
combin
vaccin
consid
similar
geograph
distribut
diseas
combin
formul
ppr
vaccin
sheep
pox
ppr
goat
pox
ppr
also
develop
chaudhari
et
al
hosamani
et
al
found
induc
protect
immun
respons
without
side
effect
major
cost
diseas
ppr
control
program
would
transport
vaccin
end
user
may
creat
opportun
dissemin
inform
technolog
henc
manag
health
problem
anim
well
vaccin
diseas
could
potenti
combin
ppr
sheep
goat
pox
pasteurellosi
brucellosi
contagi
caprin
pleuropneumonia
ccpp
fmd
addit
deworm
intern
extern
parasit
may
also
includ
control
program
well
establish
sera
morbilliviru
infect
anim
cross
react
virus
within
genu
brees
de
boer
gould
et
al
norrbi
et
al
orvel
norrbi
plowright
sheshberadaran
et
al
though
crossprotect
alway
reciproc
relationship
may
depend
upon
viru
strain
natur
host
involv
eg
cdv
protect
cattl
rpv
rpv
provid
partial
protect
ferret
cdv
imagawa
jone
et
al
sheshberadaran
et
al
rpv
protect
dog
cdv
cdv
protect
cattl
rpv
delay
et
al
inocul
pprv
vaccin
goat
elicit
antibodi
neutral
rpv
cell
cultur
though
lower
titr
neutral
pprv
couacyhymann
et
al
likewis
rpv
vaccin
strain
elicit
antibodi
goat
neutral
rpv
exhibit
trace
neutral
abil
pprv
taylor
recent
inocul
pprv
vaccin
cattl
shown
elicit
antibodi
cell
mediat
immun
respons
fail
protect
virul
rpv
challeng
holzer
et
al
two
independ
develop
pprv
vaccin
strain
along
virul
strain
pprv
use
inocul
cattl
cross
protect
virul
rpv
observ
virul
pprv
inocul
cattl
holzer
et
al
find
accord
earli
studi
crude
materi
anim
suffer
ppr
shown
protect
cattl
rinderpest
mornet
et
al
increas
diseas
outbreak
due
cdv
primat
de
vri
et
al
suggest
presenc
measl
viru
human
popul
would
prevent
diseas
caus
cdv
crossprotect
among
variou
prototyp
morbillivirus
consid
mediat
mainli
via
cellmedi
immun
rather
crossreact
antibodi
brown
mccarthi
gerber
marron
howev
antibodymedi
cross
protect
may
occur
due
presenc
neutral
antibodi
rather
due
crossreact
antibodi
fix
complement
result
death
infect
cell
without
prevent
viru
infect
cell
cultur
orvel
norrbi
sheshberadaran
et
al
might
due
conserv
epitop
present
surfac
morbilliviru
fusion
glycoprotein
orvel
norrbi
sheshberadaran
et
al
exampl
antibodi
rpv
f
protein
neutral
viru
directli
rather
presenc
complement
similar
antirpvh
antibodi
directli
neutral
sugiyama
et
al
similarli
antibodi
measl
infect
sera
cross
react
immunofluoresc
surfac
glycoprotein
cdv
absenc
cdvneutral
activ
gould
et
al
also
identifi
differ
observ
crossprotect
among
prototyp
morbillivirus
hypothes
due
inher
abil
viru
strain
replic
suffici
heterolog
host
trigger
potent
immun
respons
ii
emerg
random
natur
attenu
mutat
vaccin
strain
serial
passag
cell
cultur
prevent
revers
virul
singl
random
base
chang
sinc
mutat
uncharacter
quit
possibl
one
would
particularli
strong
effect
replicationimmunogen
viru
heterolog
host
exact
mechan
crossprotect
morbillivirus
remain
elus
extens
work
cellmedi
humor
immun
respons
need
precis
understand
cross
protect
among
morbillivirus
initi
absenc
homolog
ppr
vaccin
taylor
use
attenu
rpv
vaccin
goat
vaccin
attenu
rpv
vaccin
protect
pprv
least
month
without
transmit
challeng
viru
incontact
suscept
anim
though
vaccin
anim
develop
neutral
antibodi
primarili
direct
rpv
follow
exposur
pprv
high
antibodi
level
elicit
virus
taylor
later
homolog
ppr
vaccin
becam
avail
vaccin
ban
might
interf
grep
rinderpest
erad
globe
first
livestock
diseas
second
viral
diseas
pox
erad
globe
laboratori
around
world
also
maintain
live
rpv
could
releas
accident
could
enter
environ
caus
devast
pandem
could
also
releas
deliber
act
sabotag
bioterror
either
natur
isol
one
rescu
revers
genet
base
rpv
genom
sequenc
avail
public
domain
therefor
altern
vaccin
could
replac
tradit
live
attenu
rpv
strain
utmost
import
assumpt
led
holzer
et
al
evalu
cattl
protect
rinderpest
inocul
relat
morbilliviru
pprv
holzer
et
al
cattl
immun
use
establish
pprv
vaccin
strain
viz
develop
antibodi
cellmedi
immun
respons
fail
resist
virul
rpv
challeng
though
anim
infect
wildtyp
pprv
protect
rpv
challeng
holzer
et
al
therefor
use
ppr
vaccin
would
serv
heterolog
vaccin
candid
rinderpest
cattl
henc
would
feasibl
elimin
stock
live
rpv
held
develop
rpv
vaccin
probabl
last
studi
approv
handl
live
rpv
due
requir
bicontain
facil
work
pprv
often
restrict
attenu
vaccin
strain
overcom
issu
entir
viral
rna
polymeras
gene
larg
l
gene
remov
complement
viral
polymeras
constitut
express
host
cell
line
thu
creat
helper
cell
depend
form
pprv
grew
effici
lexpress
cell
line
cell
viru
indistinguish
normal
viru
grown
normal
facil
without
need
high
level
biocontain
baron
baron
well
establish
pprv
circul
small
rumin
subclin
infect
cattl
make
sero
posit
pprv
couacyhymann
et
al
haroun
et
al
khan
et
al
similarli
rpv
shown
subclin
infect
small
rumin
kumar
et
al
context
imper
specul
whether
antirpv
antibodi
prevent
transmiss
pprv
small
rumin
similarli
whether
presenc
antipprv
antibodi
cattl
affect
epidemiolog
transmiss
rpv
howev
virul
viru
vaccin
viru
abl
self
transmit
infect
anim
incontact
suscept
anim
review
refer
kumar
et
al
context
desir
develop
vaccin
ppr
transmit
viru
self
immun
incontact
suscept
anim
includ
cattl
though
pprv
infect
cattl
make
seroposit
yet
succeed
adapt
bovin
pprv
could
maintain
natur
independ
without
small
rumin
vaccin
anim
small
rumin
ppr
control
program
pprv
rpv
produc
similar
clinic
diseas
natur
host
rpv
caus
lethal
infect
cattl
sheep
goat
develop
subclin
diseas
contrast
pprv
caus
acut
lethal
diseas
sheep
goat
mild
infect
cattl
grep
mass
vaccin
carri
cattl
buffalo
wherea
sheep
goat
cover
couacyhymann
et
al
specul
pprv
may
emerg
rpv
natur
passag
sheep
goat
recent
time
evid
pprv
infect
cattl
buffalo
khan
et
al
suggest
possibl
emerg
bovin
pprv
therefor
becom
pertin
explor
possibl
inclus
cattl
mass
vaccin
campaign
ppr
underway
asia
africa
liveattenu
vaccin
provid
longlast
immun
well
effect
diagnost
tool
alreadi
avail
control
ppr
limit
use
current
vaccin
vaccin
anim
differenti
natur
infect
anim
would
essenti
evalu
impact
vaccin
serosurveil
program
postvaccin
sinc
diseas
also
includ
along
ppr
control
program
multidiseas
diagnost
assay
need
develop
effect
contain
diseas
order
overcom
necess
coldchain
technolog
thermost
vaccin
also
develop
besid
research
also
undertaken
develop
aerosoley
drop
vaccin
classic
level
herd
immun
requir
prevent
transmiss
viru
howev
precis
level
herd
immun
requir
block
effect
transmiss
ppr
need
investig
author
declar
conflict
interest
